Location |
Multinational |
10 |
17% |
|
Iran |
7 |
12% |
|
USA |
8 |
14% |
|
China |
6 |
10% |
|
Israel |
4 |
7% |
|
Australia |
4 |
7% |
|
India |
4 |
7% |
|
Algeria |
3 |
5% |
|
Germany |
3 |
5% |
|
South Korea |
1 |
2% |
|
Thailand |
1 |
2% |
|
Indonesia |
1 |
2% |
|
Greece |
1 |
2% |
|
Switzerland |
1 |
2% |
|
Spain |
1 |
2% |
|
Colombia |
1 |
2% |
|
UK |
1 |
2% |
|
Austria |
1 |
2% |
Input |
Single document (SD) |
39 |
67% |
|
Multiple documents (MD) |
18 |
31% |
|
Single and Multiple documents (SD and MD) |
1 |
2% |
|
Monolingual (Mono) |
58 |
100% |
|
Multilingual (Multi) |
0 |
0% |
|
Full Text (FT) |
47 |
81% |
|
Abstract (Ab) |
10 |
17% |
|
Full Text and Abstract (FT and Ab) |
1 |
2% |
|
Biomedical Research Literature (Lit) |
40 |
69% |
|
Electronic Health Record (EHR) |
11 |
19% |
|
Other biomedical related documents |
7 |
12% |
Purpose |
To facilitate clinical decision-making |
17 |
29% |
|
To facilitate biomedical research |
34 |
59% |
|
To facilitate patient health information seeking |
5 |
9% |
|
To facilitate patient health information seeking/To facilitate clinical decision-making |
1 |
2% |
|
To facilitate biomedical research/To support clinical decision-making |
1 |
2% |
|
User-oriented (U) |
16 |
28% |
|
Generic (G) |
42 |
72% |
Output |
Informative |
56 |
97% |
|
Informative and indicative |
2 |
3% |
|
Extractive (Ext) |
47 |
81% |
|
Abstractive (Abs) |
10 |
17% |
|
Extractive and Abstractive (Ext and Abs) |
1 |
2% |
Method |
Machine Learning (ML) |
4 |
7% |
|
Statistical and Computational Linguistics (Stats and CL) |
22 |
38% |
|
Computational Linguistics (CL) |
1 |
2% |
|
Machine Learning and Statistical (ML and Stats) |
1 |
2% |
|
Computational Linguistics and Machine learning (CL and ML) |
4 |
7% |
|
Statistical, machine learning and Computational Linguistics (Stats, ML and CL) |
26 |
45% |
Evaluation |
Intrinsic (I) |
51 |
88% |
|
Extrinsic (E) |
3 |
5% |
|
Intrinsic and Extrinsic (I and E) |
4 |
7% |
|
Quantitative Evaluation (Quan) |
38 |
66% |
|
Qualitative Evaluation (Qual) |
2 |
3% |
|
Quantitative and Qualitative Evaluation (Quan and Qual) |
18 |
31% |
Data and Code |
Data Publicly Available |
48 |
83% |
|
Data Partially Available |
2 |
3% |
|
Data not Publicly Available |
6 |
10% |
|
Data Details not Mentioned |
2 |
3% |
|
Source Code or Application Available |
8 |
14% |
|
Source Code or Application not Available |
51 |
88% |